Lipoic Acid in the Prevention of Acute Kidney Injury

Nephron

Volumn 134, Issue 3, 2016, Pages 133-140

  Zhang, Jun ^a   McCullough, Peter A ^a,b,c  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c Heart Hospital Baylor   (United States)

Author keywords

Antioxidant; Cardioprotection; Dihydrolipoic acid; Hypoxia; Ischemia reperfusion injury; Oxidative stress; Phosphatidylinositol 3 kinase Akt pathway; Reactive oxygen species; Renoprotection; Lipoic acid

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; THIOCTIC ACID;

ACUTE KIDNEY FAILURE; ANTIOXIDANT ACTIVITY; CARDIAC MUSCLE; CLINICAL OUTCOME; DRUG STRUCTURE; ENZYME ACTIVITY; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HUMAN; INFLAMMATION; ISCHEMIC PRECONDITIONING; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; SIGNAL TRANSDUCTION; ACUTE KIDNEY INJURY; ANIMAL; CHEMISTRY; METABOLISM; RAT;

ACUTE KIDNEY INJURY; ANIMALS; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; THIOCTIC ACID;

EID: 84986550230     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000448666     Document Type: Review

References (43)

1. McCullough PA: Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-1428.
2. Ball T, McCullough PA: Statins for the prevention of contrast-induced acute kidney injury. Nephron Clin Pract 2014; 127: 165-171.
3. Heyman SN, Rosen S, Khamaisi M, Idėe JM, Rosenberger C: Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 2010; 45: 188-195.
4. Tasanarong A, Kongkham S, Itharat A: Anti-oxidant effect of phyllanthus emblica extract prevents contrast-induced acute kidney injury. BMC Complementary Altern Med 2014; 14: 138.
5. Brezis M, Rosen S: Hypoxia of the renal medulla-its implication for disease. N Engl J Med 1995; 332: 647-655.
6. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA: Patho-physiology of contrast-induced nephropathy. Am J Cardiol 2006; 98: 14K-20K.
7. Yang Y, Yang D, Yang D, Jia R, Ding G: Role of reactive oxygen species-mediated endo-plasmic reticulum stress in contrast-induced renal tubular cell apoptosis. Nephron Exp Nephrol 2014; 128: 30-36.
8. Packer L, Witt EH, Tritschler HJ: Alpha-lipo-ic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-250.
9. Whiteman M, Tritschler H, Halliwell B: Protection against peroxynitrite-dependent tyro-sine nitration and alpha 1-antiproteinase in-activation by oxidized and reduced lipoic acid. FEBS Lett 1996; 379: 74-76.
10. Biewenga GP, Haenen GR, Bast A: The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29: 315-331.
11. Moini H, Packer L, Saris NE: Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 2002; 182: 84-90.
12. Trujillo M, Radi R: Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiois. Arch Biochem Bio-phys 2002; 397: 91-98.
13. Rezk BM, Haenen GR, van der Vijgh WJ, Bast A: Lipoic acid protects efficiently only against a specific form of peroxynitrite-induced damage. J Biol Chem 2004; 279: 9693-9697.
14. Trujillo M, Folkes L, Bartesaghi S, Kalyanara-man B, Wardman P, Radi R: Peroxynitrite-derived carbonate and nitrogen dioxide radicals readily react with lipoic and dihydroli-poic acid. Free Radic Biol Med 2005; 39: 279-288.
15. Dhalla NS, Elmoselhi AB, Hata T, Makino N: Status of myocaridla antioxidants in isch-emia-reperfusion injury. Cardiovasc Res 2000; 47: 446-456.
16. Sahna E, Parlakpinar H, Turkoz Y, Acet A: Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res 2005; 54: 491-495.
17. Freisleben HJ: Lipoic acid reduces ischemia-reperfusion injury in animal models. Toxicology 2000; 148: 159-171.
18. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM: Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009; 1790: 1149-1160.
19. Ko Km, Yiu HY: Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts. Mol Cell Biochem 2001; 220: 141-147.
20. Oh SK, Yun KH, Yoo NJ, Kim NH, Kim MS, Park BR, Jeong JW: Cardioprotective effects of alpha-lipoic acid on myocardial reperfu-sion injury: suppression of reactive oxygen species generation and activation of mitogen-activated protein kinase. Korean Circ J 2000; 39: 359-366.
21. Wang X, Yu Y, Ji L, Liang X, Zhang T, Hai CX: Alpha-lipoic acid protects against myocardial ischemia/reperfusion injury via multiple target effects. Food Chem Toxicol 2011; 49: 2750-2757.
22. He L, Liu B, Dai Z, Zhang HF, Zhang YS, Luo XJ, Ma QL, Peng J: Alpha lipoic acid protects heart against myocardial ischemia-reperfu-sion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur J Pharmacol 2012; 678: 32-38.
23. Deng C, Sun Z, Tong G, Yi W, Ma L, Zhao B, Cheng L, Zhang J, Cao F, Yi D: α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfu-sion injury through activation of PI3K/Akt/ Nrf2 pathway. PLoS One 2013; 8:e58371.
24. Takaoka M, Ohkita M, Kobayashi Y, Yuba M, Matsumura Y: Protective effect of alpha-lipo-ic acid against ischaemic acute renal failure in rats. Clin Exp Pharmacol Physiol 2002; 29: 189-194.
25. Sehirli O, Sener E, Cetinel S, Yüksel M, Gedik N, Sener G: Alpha-lipoic acid protects against renal ischaemia-reperfusion injury in rats. Clin Exp Pharmacol Physiol 2008; 35: 249-255.
26. Bae EH, Lee KS, Lee J, Ma SK, Kim NH, Choi KC, Frøkiaer J, Nielsen S, Kim SY, Kim SZ, Kim SH, Kim SW: Effects of alpha-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats. Am J Physiol Renal Physiol 2008; 294:F272-F280.
27. Koga H, Hagiwara S, Kusaka J, Goto K, Uchi-no T, Shingu C, Kai S, Noguchi T: New α-lipoic acid derivative, DHL-HisZn, ameliorates renal ischemia-reperfusion injury in rats. J Surg Res 2012; 174: 352-358.
28. Cremer DR, Rabeler R, Roberts A, Lynch B: Safety evaluation of alpha-lipoic acid (ALA). Regul Toxicol Pharmacol 2006; 46: 29-41.
29. Cremer DR, Rabeler R, Roberts A, Lynch B: Long-term safety of alpha-lipoic acid (ALA) consumption: a 2-year study. Regul Toxicol Pharmacol 2006; 46: 193-201.
30. Müller C, Dünschede F, Koch E, Vollmar AM, Kiemer AK: Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol 2003; 285:G769-G778.
31. Serbinova E, Khwaja S, Reznick AZ, Packer L: Thioctic acid protects against ischemia-reper-fusion injury in the isolated perfused Langen-dorff heart. Free Radic Res Commun 1992; 17: 49-58.
32. Haramaki N, Packer L, Assadnazari H, Zim-mer G: Cardiac recovery during post-isch-emic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Bio-chem Biophys Res Commun 1993; 196: 1101-1107.
33. Scheer B, Zimmer G: Dihydrolipoic acid prevents hypoxic/reoxygenation and peroxida-tive damage in rat heart mitochondria. Arch Biochem Biophys 1993; 302: 385-390.
34. Somani SM, Husain K, Whitworth C, Trammel GL, Malafa M, Rybak LP: Dose-dependent protection by lipoic acid against cisplat-in-induced nephrotoxicity in rats: antioxi-dant defense system. Pharmacol Toxicol 2000; 86: 234-241.
35. Oymak O: Contrast media induced irreversible acute renal failure in a patient treated with intraperitoneal cisplatin. Clin Nephrol 1995; 44: 135-136.
36. Packer L, Kraemer K, Rimbach G: Molecular aspects of lipoic acid in the prevention of diabetes complication. Nutrition 2001; 17: 888-895.
37. Oudit GY, Penninger JM: Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 2009; 82: 250-260.
38. Duronio V: The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 2008; 415: 333-344.
39. Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, Abdellatif M: MicroRNA-21 is a downstream effector of AKT that mediates its anti-apoptotic effects via suppression of Fas li-gand. J Biol Chem 2010; 285: 20281-20290.
40. Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T, Schaub MC, Zaugg M: Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res 2006; 72: 152-162.
41. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM: Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002; 110: 737-749.
42. Xu P, Wang J, Yang ZW, Lou X-l, Chen C: Regulatory roles of the PI3K/Akt signaling pathway in rats with severe acute pancreatitis. PLoS One 2013; 8:e81767.
43. Rong R, Xijun X: Erythropoietin pretreat-ment suppresses inflammation by activating the PI3K/Akt signaling pathway in myocar-dial ischemia-reperfusion injury. Exp Ther Med 2015; 10: 413-418.